EYEPOINT PHARMACEUTICALS INC's ticker is and the CUSIP is 30233G950. A total of 3 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | -100.0% | 1 | -98.1% | 0.00% | – |
| Q2 2020 | $3,000 | -40.0% | 52 | +2.0% | 0.00% | – |
| Q1 2020 | $5,000 | – | 51 | +920.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 5 | -50.0% | 0.00% | – |
| Q4 2018 | $1,000 | -98.4% | 10 | -94.3% | 0.00% | – |
| Q3 2018 | $62,000 | +1966.7% | 176 | +877.8% | 0.00% | – |
| Q2 2018 | $3,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 36,000 | $27,000 | 0.00% |
| SIMPLEX TRADING, LLC | 52 | $3,000 | 0.00% |